Taysha Gene Therapies, Inc. (TSHA) has a market capitalization of $1.18B and trades at $4.71. The 52-week range is 1.05-6.02.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.9, Earnings Per Share (EPS) of $-0.34, annual revenue of $9.77M.
The stock has a beta of 1.08, operates in the Healthcare sector.
